v3.25.2
Acquisition (Tables)
 6 Months Ended
Jun. 28, 2025
Business Combinations [Abstract]  
Preliminary Purchase Price Allocation as of Acquisition Date

The preliminary purchase price allocation as of the acquisition date, reflecting measurement period adjustments made during the respective period, are as follows (amounts in thousands):

 

Entity

Thrive

 

Acquisition Date

June 2, 2025

 

Cash consideration

$

15,855

 

Share-based consideration

 

59,838

 

Total

$

75,693

 

 

 

 

Cash and cash equivalents

$

1,002

 

Patient accounts receivable

 

20,050

 

Receivables under insured programs

 

306

 

Prepaid expenses

 

494

 

Other current assets

 

308

 

Property and equipment

 

131

 

Operating lease right of use assets

 

1,835

 

Intangible assets - licenses

 

5,000

 

Intangible assets - trade names

 

540

 

Receivables under insured programs - long term

 

1,439

 

Other long-term assets

 

1,095

 

 

 

 

Accounts payable and other accrued liabilities

 

1,754

 

Accrued payroll and employee benefits

 

4,322

 

Current portion of insurance reserves

 

679

 

Current portion of operating lease liabilities

 

741

 

Other current liabilities

 

9,935

 

Long-term insurance reserves

 

2,160

 

Operating lease liabilities, less current portion

 

1,094

 

 

 

 

Total identifiable net assets

 

11,515

 

Goodwill

 

64,178

 

Total

$

75,693

 
Preliminary Goodwill from Merger Allocated to Segments Preliminary goodwill from the Merger was allocated to segments as follows (amounts in thousands):

 

 

PDS

 

 

HHH

 

 

MS

 

 

Total

 

Balance at December 28, 2024 and March 29, 2025, net (1)

$

897,728

 

 

$

46,188

 

 

$

110,636

 

 

$

1,054,552

 

Acquisition

 

64,178

 

 

 

-

 

 

 

-

 

 

 

64,178

 

Balance at June 28, 2025, net (1)

 

961,906

 

 

 

46,188

 

 

 

110,636

 

 

 

1,118,730

 

 

(1) Goodwill balance is net of accumulated impairment losses of $608.0 million for PDS, $119.8 million for MS, and $487.4 million for HHH.